Compound Information
Test on : RBC, Metz
Compound Name
RBC, Metz : SKI II
Inchikey
Same : ZFGXZJKLOFCECI-N
RBC, Metz : ZFGXZJKLOFCECI-UHFFFAOYSA-N
ChemSpider
RBC, Metz : 659133
Pubchem CID
RBC, Metz : 753704
ChEMBL
RBC, Metz : CHEMBL1076555
|
DRx |
RBC |
Metz |
Millipore |
GPCR |
bioactivity |
Kd (nM) |
Remain Activity (%) |
Ki (nM) |
Remain Activity (%) |
Inhibition (%) |
active criteria |
<3000nM |
<50% |
<1000nM |
<50% |
>50% |
AGC
AGC - PDK1
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PDK1 | inactive (101.17%) | - |
AGC - Akt
Bioactivity |
---|
Kinase | RBC | Metz |
---|
AKT1 | inactive (106.23%) | - |
AKT2 | inactive (96.4%) | - |
AKT3 | inactive (105.3%) | - |
AGC - DMPK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
DMPK1 | inactive (102.03%) | - |
MRCKa | inactive (87.05%) | - |
MRCKb | inactive (107.96%) | - |
ROCK1 | inactive (102.8%) | - |
ROCK2 | inactive (99.37%) | - |
AGC - GRK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
BARK1 | inactive (100.43%) | - |
BARK2 | inactive (97.61%) | - |
GPRK4 | inactive (90.54%) | - |
GPRK5 | inactive (92.01%) | - |
GPRK6 | inactive (100.3%) | - |
GPRK7 | inactive (108.72%) | - |
AGC - RSK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
MSK1 | inactive (108.73%) | - |
MSK2 | inactive (91.48%) | - |
p70S6K | inactive (103.62%) | - |
p70S6Kb | inactive (99.76%) | - |
RSK2 | inactive (107.06%) | - |
RSK4 | inactive (116.97%) | - |
RSK1 | inactive (97.66%) | - |
RSK3 | inactive (100.54%) | - |
AGC - PKA
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PKACg | inactive (111.64%) | - |
PRKX | inactive (99.62%) | - |
PKACa | inactive (104.53%) | - |
AGC - PKC
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PKCa | inactive (112.55%) | - |
PKCd | inactive (86.88%) | - |
PKCe | inactive (99.63%) | - |
PKCh | inactive (96.33%) | - |
PKCg | inactive (87.29%) | - |
PKCi | inactive (99.46%) | - |
PKCt | inactive (122.55%) | - |
PKCz | inactive (105.25%) | - |
PKCb | inactive (94.73%) | - |
AGC - PKG
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PKG2 | inactive (92.95%) | - |
PKG1 | inactive (98.53%) | - |
AGC - PKN
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PKN1 | inactive (99.5%) | - |
PKN2 | inactive (93.82%) | - |
AGC - SGK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
SGK1 | inactive (106.37%) | - |
SGK2 | inactive (107.74%) | - |
SGK3 | inactive (97.99%) | - |
AGC - NDR
Bioactivity |
---|
Kinase | RBC | Metz |
---|
NDR1 | inactive (98.21%) | - |
TK
TK - Abl
Bioactivity |
---|
Kinase | RBC | Metz |
---|
ABL1 | inactive (99.75%) | - |
ABL2 | inactive (93.42%) | - |
TK - Ack
Bioactivity |
---|
Kinase | RBC | Metz |
---|
ACK | inactive (103.33%) | - |
TK - ALK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
ALK | inactive (110.95%) | - |
LTK | inactive (103.53%) | - |
TK - Axl
Bioactivity |
---|
Kinase | RBC | Metz |
---|
AXL | inactive (98.46%) | - |
MER | inactive (97.12%) | - |
TYRO3 | inactive (102.27%) | - |
TK - Src
Bioactivity |
---|
Kinase | RBC | Metz |
---|
BLK | inactive (100.13%) | - |
BRK | inactive (87.37%) | - |
SRC | inactive (95.06%) | - |
FGR | inactive (96.4%) | - |
FRK | inactive (105.77%) | - |
FYN | inactive (101.92%) | - |
HCK | inactive (96.06%) | - |
LCK | inactive (99.84%) | - |
SRM | inactive (105.96%) | - |
YES | inactive (99.16%) | - |
LYN | inactive (100.25%) | - |
TK - Tec
Bioactivity |
---|
Kinase | RBC | Metz |
---|
BMX | inactive (103.02%) | - |
BTK | inactive (107.36%) | - |
ITK | inactive (95.37%) | - |
TEC | inactive (120.21%) | - |
TXK | inactive (100.48%) | - |
TK - PDGFR
Bioactivity |
---|
Kinase | RBC | Metz |
---|
KIT | inactive (92.01%) | - |
FLT3 | inactive (99%) | - |
FMS | inactive (104.1%) | - |
PDGFRb | inactive (106.86%) | - |
PDGFRa | inactive (100.87%) | - |
TK - Csk
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CSK | inactive (101.15%) | - |
CTK | inactive (95.55%) | - |
TK - DDR
Bioactivity |
---|
Kinase | RBC | Metz |
---|
DDR2 | inactive (94.12%) | - |
TK - EGFR
Bioactivity |
---|
Kinase | RBC | Metz |
---|
EGFR | inactive (95.32%) | - |
ErbB2 | inactive (96.9%) | - |
ErbB4 | inactive (83.26%) | - |
TK - Eph
Bioactivity |
---|
Kinase | RBC | Metz |
---|
EphA1 | inactive (92.58%) | - |
EphA2 | inactive (105.1%) | - |
EphA3 | inactive (109.81%) | - |
EphA4 | inactive (104.33%) | - |
EphA5 | inactive (92.64%) | - |
EphA6 | inactive (100.78%) | - |
EphA7 | inactive (97.71%) | - |
EphA8 | inactive (93.45%) | - |
EphB1 | inactive (105.38%) | - |
EphB2 | inactive (101.11%) | - |
EphB3 | inactive (102.62%) | - |
EphB4 | inactive (89.57%) | - |
TK - FAK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
FAK | inactive (99.45%) | - |
PYK2 | inactive (100.02%) | - |
TK - Fer
Bioactivity |
---|
Kinase | RBC | Metz |
---|
FER | inactive (90.35%) | - |
FES | inactive (103.24%) | - |
TK - FGFR
Bioactivity |
---|
Kinase | RBC | Metz |
---|
FGFR1 | inactive (82.55%) | - |
FGFR2 | inactive (103.56%) | - |
FGFR3 | inactive (96.54%) | - |
FGFR4 | inactive (71.64%) | - |
TK - VEGFR
Bioactivity |
---|
Kinase | RBC | Metz |
---|
FLT1 | inactive (82.28%) | - |
FLT4 | inactive (101.12%) | - |
KDR | inactive (101.18%) | - |
TK - InsR
Bioactivity |
---|
Kinase | RBC | Metz |
---|
IGF1R | inactive (102.01%) | - |
IRR | inactive (98.76%) | - |
INSR | inactive (88.86%) | - |
TK - JakA
Bioactivity |
---|
Kinase | RBC | Metz |
---|
JAK1 | inactive (97.05%) | - |
JAK2 | inactive (101.29%) | - |
JAK3 | inactive (92.21%) | - |
TYK2 | inactive (109.62%) | - |
TK - Musk
Bioactivity |
---|
Kinase | RBC | Metz |
---|
MUSK | inactive (99.51%) | - |
TK - Ret
Bioactivity |
---|
Kinase | RBC | Metz |
---|
RET | inactive (99.01%) | - |
TK - Met
Bioactivity |
---|
Kinase | RBC | Metz |
---|
RON | inactive (92.51%) | - |
MET | inactive (99.39%) | - |
TK - Sev
Bioactivity |
---|
Kinase | RBC | Metz |
---|
ROS | inactive (96.91%) | - |
TK - Syk
Bioactivity |
---|
Kinase | RBC | Metz |
---|
SYK | inactive (93.84%) | - |
ZAP70 | inactive (94.67%) | - |
TK - Tie
Bioactivity |
---|
Kinase | RBC | Metz |
---|
TIE2 | inactive (104.02%) | - |
TK - Trk
Bioactivity |
---|
Kinase | RBC | Metz |
---|
TRKA | inactive (104%) | - |
TRKB | inactive (107.01%) | - |
TRKC | inactive (102.16%) | - |
TKL
TKL - STKR
Bioactivity |
---|
Kinase | RBC | Metz |
---|
ALK1 | inactive (103.03%) | - |
ALK2 | inactive (94.92%) | - |
ALK4 | inactive (89.53%) | - |
TGFbR1 | inactive (99.87%) | - |
TGFbR2 | inactive (112.18%) | - |
TKL - RAF
Bioactivity |
---|
Kinase | RBC | Metz |
---|
ARAF | inactive (101.29%) | - |
BRAF | inactive (90.65%) | - |
RAF1 | inactive (95.7%) | - |
TKL - IRAK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
IRAK1 | inactive (122.73%) | - |
IRAK4 | inactive (111.45%) | - |
TKL - LISK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
LIMK1 | inactive (90.45%) | - |
TKL - LRRK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
LRRK2 | inactive (98.74%) | - |
TKL - MLK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
MLK1 | inactive (80.95%) | - |
MLK2 | inactive (100.08%) | - |
MLK3 | inactive (95.28%) | - |
TAK1 | inactive (95.3%) | - |
ZAK | inactive (92.74%) | - |
TKL - RIPK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
RIPK2 | inactive (96.4%) | - |
CAMK
CAMK - CAMKL
Bioactivity |
---|
Kinase | RBC | Metz |
---|
NuaK1 | inactive (90.71%) | - |
BRSK1 | inactive (101.64%) | - |
BRSK2 | inactive (100.88%) | - |
CHK1 | inactive (99.39%) | - |
LKB1 | inactive (91.09%) | - |
MARK1 | inactive (93.73%) | - |
MARK3 | inactive (95.28%) | - |
MARK4 | inactive (102.81%) | - |
MELK | inactive (100.36%) | - |
PASK | inactive (130.95%) | - |
QIK | inactive (90.67%) | - |
NuaK2 | inactive (136.73%) | - |
MARK2 | inactive (102.05%) | - |
AMPKa1 | - | - |
CAMK - CAMK1
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CaMK1a | inactive (110.83%) | - |
CaMK1b | inactive (100.32%) | - |
CaMK1d | inactive (103%) | - |
CaMK1g | inactive (106.01%) | - |
CaMK4 | inactive (99.74%) | - |
CAMK - CAMK2
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CaMK2a | inactive (106.02%) | - |
CaMK2b | inactive (85.79%) | - |
CaMK2d | inactive (98.76%) | - |
CaMK2g | inactive (90.62%) | - |
CAMK - RAD53
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CHK2 | inactive (97.94%) | - |
CAMK - DAPK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
DAPK1 | inactive (100.96%) | - |
DAPK2 | inactive (106.92%) | - |
DRAK1 | inactive (98.74%) | - |
DAPK3 | inactive (102.79%) | - |
CAMK - DCAMKL
Bioactivity |
---|
Kinase | RBC | Metz |
---|
DCLK2 | inactive (98.45%) | - |
DCLK1 | - | - |
CAMK - MAPKAPK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
MAPKAPK2 | inactive (100.25%) | inactive (7943.28nM) |
MAPKAPK3 | inactive (94.1%) | - |
MAPKAPK5 | inactive (96.82%) | - |
MNK1 | inactive (98.93%) | - |
MNK2 | inactive (84.55%) | - |
CAMK - MLCK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
smMLCK | inactive (103.83%) | - |
skMLCK | inactive (97.05%) | - |
CAMK - PHK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PHKg1 | inactive (96.45%) | - |
PHKg2 | inactive (99.93%) | - |
CAMK - PIM
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PIM1 | inactive (103.41%) | - |
PIM2 | inactive (105.79%) | - |
PIM3 | inactive (114%) | inactive (3162.28nM) |
CAMK - PKD
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PKD1 | inactive (96.78%) | - |
PKD3 | inactive (97.66%) | - |
PKD2 | inactive (102.19%) | - |
CAMK - TSSK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
TSSK1 | inactive (118.68%) | - |
TSSK2 | inactive (102.38%) | - |
CAMK - STK33
Bioactivity |
---|
Kinase | RBC | Metz |
---|
STK33 | inactive (97.53%) | - |
STE
STE - STE11
Bioactivity |
---|
Kinase | RBC | Metz |
---|
MAP3K5 | inactive (107.61%) | - |
MAP3K2 | inactive (92.13%) | - |
MAP3K3 | inactive (101.06%) | - |
STE - STE-Unique
Bioactivity |
---|
Kinase | RBC | Metz |
---|
COT | inactive (94.92%) | - |
NIK | inactive (101.88%) | - |
STE - STE20
Bioactivity |
---|
Kinase | RBC | Metz |
---|
GCK | inactive (102.83%) | - |
HGK | inactive (88.89%) | active (1000nM) |
KHS1 | inactive (110.41%) | - |
LOK | inactive (96.56%) | - |
MINK | inactive (102.56%) | inactive (2511.89nM) |
MST1 | inactive (106.29%) | - |
MST2 | inactive (114.37%) | - |
MST3 | inactive (94.07%) | - |
MST4 | inactive (105.23%) | - |
OSR1 | inactive (88.83%) | - |
PAK1 | inactive (99.38%) | - |
PAK2 | inactive (86.97%) | - |
PAK3 | inactive (124.44%) | - |
PAK4 | inactive (102.14%) | - |
PAK5 | inactive (105.36%) | - |
PAK6 | inactive (100.27%) | - |
SLK | inactive (109.91%) | - |
YSK1 | inactive (112.54%) | - |
STLK3 | inactive (94.23%) | - |
TAO1 | inactive (97.05%) | - |
TAO2 | inactive (100.89%) | - |
TAO3 | inactive (101.4%) | - |
MYO3B | inactive (98.71%) | - |
STE - STE7
Bioactivity |
---|
Kinase | RBC | Metz |
---|
MAP2K1 | inactive (90.65%) | - |
MAP2K2 | inactive (109.21%) | - |
MAP2K6 | inactive (93.99%) | - |
Other
Other - Aur
Bioactivity |
---|
Kinase | RBC | Metz |
---|
AurA | inactive (89.44%) | - |
AurB | inactive (101.77%) | - |
AurC | inactive (96.95%) | - |
Other - CAMKK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CaMKK1 | inactive (123.89%) | - |
CaMKK2 | inactive (101.4%) | - |
Other - Haspin
Bioactivity |
---|
Kinase | RBC | Metz |
---|
Haspin | inactive (100.4%) | - |
Other - IKK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
IKKa | inactive (103.62%) | - |
IKKb | inactive (104.37%) | - |
IKKe | inactive (95.93%) | - |
TBK1 | inactive (95.24%) | - |
Other - NEK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
NEK1 | inactive (104.34%) | - |
NEK11 | inactive (77.05%) | - |
NEK2 | inactive (110.18%) | - |
NEK4 | inactive (104.35%) | - |
NEK6 | inactive (95.22%) | - |
NEK7 | inactive (105.89%) | - |
NEK9 | inactive (90.57%) | - |
NEK3 | inactive (98.4%) | - |
Other - TOPK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PBK | inactive (100.05%) | - |
Other - PLK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PLK1 | inactive (105.72%) | - |
PLK2 | inactive (105.19%) | - |
PLK3 | inactive (97.44%) | - |
PLK4 | - | - |
Other - SgK496
Bioactivity |
---|
Kinase | RBC | Metz |
---|
SgK496 | inactive (103.86%) | - |
Other - NAK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
MPSK1 | inactive (105.65%) | - |
Other - TTK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
TTK | inactive (87.57%) | - |
Other - ULK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
ULK1 | inactive (84.21%) | - |
ULK2 | inactive (101.26%) | - |
ULK3 | inactive (94.44%) | - |
Other - WEE
Bioactivity |
---|
Kinase | RBC | Metz |
---|
Wee1 | inactive (93.19%) | - |
Other - WNK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
Wnk2 | inactive (101.17%) | - |
Wnk3 | inactive (98.71%) | - |
Other - TLK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
TLK2 | inactive (121.03%) | - |
Other - CDC7
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CDC7 | - | - |
CK1
CK1
Test Member No. in Family |
---|
Family | no. Member on 518kinase | RBC | Metz |
---|
CK1 | 7 | 6 | 5 |
VRK | 3 | 1 | - |
CK1 - CK1
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CK1d | inactive (104.91%) | - |
CK1g1 | inactive (94.54%) | - |
CK1g2 | inactive (91.81%) | - |
CK1g3 | inactive (102.9%) | - |
CK1a | inactive (96.43%) | - |
CK1e | inactive (103.24%) | - |
CK1 - VRK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
VRK1 | inactive (99.83%) | - |
CMGC
CMGC - CK2
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CK2a1 | inactive (101.35%) | - |
CK2a2 | inactive (96.88%) | - |
CMGC - CLK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CLK1 | inactive (103.54%) | - |
CLK2 | inactive (102.41%) | - |
CLK3 | inactive (92.65%) | - |
CLK4 | inactive (98.83%) | - |
CMGC - DYRK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
DYRK1A | inactive (96.61%) | - |
DYRK1B | inactive (105.64%) | - |
DYRK2 | inactive (91.23%) | - |
DYRK3 | inactive (101.1%) | - |
DYRK4 | inactive (95.93%) | - |
HIPK1 | inactive (100%) | - |
HIPK2 | inactive (90.87%) | - |
HIPK3 | inactive (108.76%) | - |
HIPK4 | inactive (100.6%) | - |
CMGC - MAPK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
Erk1 | inactive (103.5%) | - |
Erk2 | inactive (105.94%) | - |
JNK3 | inactive (101.29%) | - |
NLK | inactive (100.81%) | - |
p38a | inactive (98.57%) | - |
p38b | inactive (105.23%) | - |
p38d | inactive (106.68%) | - |
p38g | inactive (106.39%) | - |
JNK1 | inactive (99.99%) | - |
JNK2 | inactive (98.31%) | - |
CMGC - GSK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
GSK3A | inactive (97.44%) | - |
GSK3B | inactive (109.7%) | - |
CMGC - SRPK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
MSSK1 | inactive (98.14%) | - |
SRPK1 | inactive (103.33%) | - |
SRPK2 | inactive (104.31%) | - |
CMGC - CDK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
CDC2 | - | - |
CDK2 | - | - |
CDK5 | - | - |
CDK8 | - | - |
CDK7 | - | - |
CDK9 | - | - |
CDK11 | - | - |
Atypical
Atypical
Test Member No. in Family |
---|
Family | no. Member on 518kinase | RBC | Metz |
---|
PDHK | 5 | 1 | - |
Alpha | 6 | - | 1 |
Atypical - PDHK
Bioactivity |
---|
Kinase | RBC | Metz |
---|
PDHK1 | inactive (101.17%) | - |
Atypical - Alpha
Bioactivity |
---|
Kinase | RBC | Metz |
---|
eEF2K | - | - |